IMMUNOGLOBULIN COMPRISING PREDOMINANTLY A MAN7GLCNAC2, MAN8GLCNAC2 GLYCOFORM

摘要

The present invention relates to immunoglobulin glycoprotein compositions having predominant N-glycan structures on an immunoglobulin glycoprotein which confer a specific effector function. Additionally, the present invention relates to pharmaceutical compositions comprising an antibody having a particular enriched N-glycan structure, wherein said N-glycan structure is selected from the group consisting of Man7GlcNAc2 and Man8G1cNAc2.